These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37903974)

  • 21. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
    Chen W; Yang Z; Chen Y
    Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
    Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
    Front Immunol; 2022; 13():990790. PubMed ID: 36248822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.
    Gao W; Li L; Han X; Liu S; Li C; Yu G; Zhang L; Zhang D; Liu C; Meng E; Hong S; Wang D; Guo P; Shi G
    BMC Cancer; 2021 Mar; 21(1):331. PubMed ID: 33789609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
    Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma.
    Yang L; Zeng LF; Hong GQ; Luo Q; Lai X
    J Immunol Res; 2022; 2022():6535009. PubMed ID: 35865652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.
    Li P; Ma X; Huang D; Gu X
    Int J Immunopathol Pharmacol; 2023; 37():3946320231218179. PubMed ID: 38054921
    [No Abstract]   [Full Text] [Related]  

  • 32. A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients.
    Zhao C; Zhang Z; Tao J
    Curr Oncol; 2022 Sep; 29(10):6992-7011. PubMed ID: 36290827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic stratification based on m
    Liu P; Zhu Z; Ma J; Wei L; Han Y; Shen E; Tan X; Chen Y; Cai C; Guo C; Peng Y; Gao Y; Liu Y; Huang Q; Gao L; Li Y; Jiang Z; Wu W; Liu Y; Zeng S; Li W; Feng Z; Shen H
    Front Immunol; 2022; 13():951529. PubMed ID: 36159831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wen H; Ji T; Lin L; Cheng N; Zhu K; Cao L
    Mediators Inflamm; 2023; 2023():2664370. PubMed ID: 37181808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
    Yan J; Cao J; Chen Z
    BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Prognostic Signatures of Hepatocellular Carcinoma and the Potential Implications in Tumor Immune Microenvironment.
    Chen H; Jiang Z; Yang B; Yan G; Wang X; Zang S
    Comb Chem High Throughput Screen; 2022; 25(6):998-1004. PubMed ID: 33687891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.